investor_presentation
Dynagas LNG
Loading viewer...
investor_presentation
Format: PDF investor_presentation
QIAGEN held a Capital Markets Day on June 17, 2024, presenting its 2028 strategy and growth targets. The agenda covered sample technologies, QIAcuity dPCR, molecular diagnostics products including QuantiFERON TB and QIAstat-Dx, and the QIAGEN Digital Insights business area.
conference
15 Pages
investor_presentation
17 Pages
Group 1 Automotive
investor_presentation
Dynagas LNG
Regeneron Pharmaceuticals Investor Presentation — November 2019
investor_presentationinvestor_presentation
23 Pages
Regeneron Pharmaceuticals, Inc.